---
title: 'Join Our Talent Community at Click Therapeutics'
canonical: 'https://feeny.ai/job/join-our-talent-community-click-therapeutics-new-york-ny-or-boston-26svay3800kv'
type: 'job'
last_seen: '2026-09-15'
---

# Join Our Talent Community at Click Therapeutics

- **Company:** Click Therapeutics
- **Location:** New York NY OR Boston, MA
- **Posted:** 2024-12-16
- **Last confirmed live:** 2026-09-15
- **Apply:** https://job-boards.greenhouse.io/clicktherapeutics/jobs/7776029002

## Job description

Who We Are:

Click Therapeutics, Inc., develops, validates, and commercializes software as prescription medical treatments for people with unmet medical needs. As a leading innovator of Digital Therapeutics™, Click delivers accessible, clinically proven, FDA-regulated prescription treatments to the smartphone in your hand. Click’s treatments are defined by a commitment to applying technical and scientific rigor and patient-centric design to the development process. This results in uniquely engaging experiences that achieve compelling clinical outcomes for patients seeking new treatment options. Click Therapeutics continuously expands and refines its platform with novel cognitive, behavioral and neuromodulatory mechanisms of action and advanced data-driven tools such as artificial intelligence and machine learning. The digital therapeutics under development on Click’s platform address diverse areas of therapeutic need, including indications in psychiatry, neurology, oncology, immunology, and cardiometabolic diseases. Consistently named a best place to work, Click fosters an inclusive, diverse workforce of innovators, clinicians, scientists, researchers, designers, technologists, engineers and more, united in a common mission to provide patients everywhere access to safe and effective prescription digital therapeutics. For more information, visit [www.clicktherapeutics.com](http://www.clicktherapeutics.com/) and connect with us on [LinkedIn.](https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fwww.linkedin.com%2Fcompany%2Fclick-therapeutics-inc-&esheet=53547717&newsitemid=20230906733059&lan=en-US&anchor=LinkedIn&index=2&md5=e43cc28868d0d6b06d80ed8acc219d68)

About Our Talent Community:

Don't see a perfect fit for your skills right now? We're constantly growing and adding new positions. Join our talent community to stay informed about upcoming opportunities that align with your unique background and experience. Be the first to know about exciting new roles!

While joining our talent community doesn't constitute a formal job application, it does give you a distinct advantage. We'll proactively reach out with new positions that match your profile, ensuring you never miss a perfect opportunity.

Equal Employment Opportunity:

Click Therapeutics is committed to equal opportunity in the terms and conditions of employment for all employees and job applicants without regard to race, color, religion, sex, sexual orientation, age, gender identity or gender expression, national origin, disability or veteran status. Click Therapeutics also complies with all applicable national, state and local laws governing nondiscrimination in employment as well as employment eligibility verification requirements of the Immigration and Nationality Act. All applicants must have authorization to work for Click Therapeutics in the U.S. In certain circumstances it may be advantageous to Click Therapeutics to support the application(s) for temporary visa classification and/or sponsor applications for permanent residence so that a foreign national colleague can accept or remain in a work assignment in the U. S. For certain classes of temporary visas, the resulting work authorization may be specific to Click Therapeutics and the specific job and/or work site. Click Therapeutics may at its business discretion decide to or refrain from obtaining, maintaining and/or extending the temporary visa status and/or sponsoring a colleague for permanent residency and /or employment eligibility, considering factors such as availability of qualified U.S. workers and the colleague's long-term prospects for securing lawful permanent residence, among other reasons. Employment applicants requiring immigration sponsorship must disclose, when initial application for employment is made, whether or not they are legally authorized to work for Click Therapeutics in the U.S. and, if so, whether that authorization permits them to work in the job they seek. In no case should Click Therapeutics support of a colleague's temporary visa application or sponsorship of a colleague for permanent residence be construed to guarantee success of that application or amend or otherwise invalidate the "at-will" employment relationship between the colleague and Click Therapeutics.

Recruitment Phishing Scams:

Fake job advertisements and offers are increasingly appearing on the internet. If you have encountered a job posting or have been approached with a job offer that you suspect may be fraudulent, we strongly recommend you do not respond and report it to the [Federal Trade Commission](https://reportfraud.ftc.gov/#/) and the FBI at https://www.ic3.gov/Home/ComplaintChoice.You can also contact our team at recruitment@clicktherapeutics.com to report details of your experience.

Please be mindful of the following:

- Click Therapeutics will only reach out to you through an “@clicktherapeutics.com” email address.

- Other than your email address or telephone number, which you may provide via a job application portal, Click Therapeutics will never ask you to provide personally identifiable information about yourself (such as a Social Security Number or Driver’s License Number) via a messaging application (like that used on the LinkedIn platform or Microsoft Teams).

- Click Therapeutics will conduct interviews face-to-face over Zoom.

- All job postings will be listed on the Click Therapeutics official career page. If someone contacts you about a job or position that is not listed on the official career page, please contact the Click Therapeutics recruitment team at the contact information below.

If you have any questions regarding the validity of a recruitment inquiry or an interview, please contact the Click’s recruitment team at recruitment@clicktherapeutics.com to confirm before proceeding.

## About Click Therapeutics

## Company Overview
- **One-liner**: Click Therapeutics develops, validates, and commercializes software as prescription medical treatments (prescription digital therapeutics) for people with unmet medical needs in psychiatry, neurology, and other therapeutic areas.
- **Entity Type**: Private (Series D, pre-IPO)
- **Headquarters**: New York, New York, USA (80 White Street, New York, NY 10013)
- **Founded**: 2012
- **Founders**: David Benshoof Klein

## Core Business
- **Primary Industry**: Digital Therapeutics / Prescription Digital Therapeutics (healthcare technology)
- **Target Customers**: B2B (pharmaceutical partners, payers, providers); B2C (patients prescribed by physicians)
- **Mission**: "Provide patients everywhere access to safe and effective prescription digital therapeutics" and "redefine modern medicine with patient-centric digital treatments"

## Products & Services
Click Therapeutics’ products are software-based prescription treatments delivered via smartphone, often developed in collaboration with pharmaceutical partners.

- **CT-152 (marketed as Rejoyn)**: First and only FDA-cleared prescription app for the adjunctive treatment of major depressive disorder (MDD) symptoms. Developed in collaboration with Otsuka. Phase 3 trial (Mirai study) completed.
- **CT-132**: Investigational prescription digital therapeutic for the preventive treatment of episodic migraine. Met primary endpoint in the ReMMi-D pivotal trial. FDA authorized (breakthrough device designation). Partner: (self-developed).
- **CT-155**: Investigational PDT for negative symptoms in schizophrenia. Met primary endpoint in the CONVOKE study (Phase 2). Currently in Phase 3 pivotal/regulatory stage. Partner: Boehringer Ingelheim.
- **AspyreRx**: FDA-authorized PDT for type 2 diabetes. Partner: Self-developed.
- **Click SE Platform**: Software-Enhanced Drugs™ – combines software with pharmacotherapy to create drug-plus-software combination treatments.
- **Clickheart™**: Pipeline product for cardiovascular indications (early-stage).
- **Pipeline**: Additional programs in oncology, multiple sclerosis, and other therapeutic areas (various phases from discovery to Phase 3).

## Market Standing
- **Valuation**: Not publicly available
- **Key Metric – Total Funding**: $252.43 million raised (as of most recent Series D) per [CB Insights](https://www.cbinsights.com/company/click-therapeutics)
- **Recent Funding**: Series D investment from Boehringer Ingelheim (announced in 2025); amount not disclosed separately but total last raise ~$50M per CB Insights.
- **Notable Investors/Partners**: HIG, Accelmed, Sanofi Ventures, Boehringer Ingelheim, Otsuka, Ultrahuman (strategic partnership for migraine management)
- **Growth Signals**:
  - Listed on Deloitte Technology Fast 500 (2024) for two consecutive years
  - Named to BuiltIn Best Places to Work in NYC (2025) for four consecutive years
  - DHNY Hall of Fame 2025 – pioneer in NYC digital health ecosystem
  - Rapidly growing pre-IPO company in a nascent space

## Competitive Advantages
- **AI-Enabled Platform**: Proprietary multimodal, platform-based approach combining neuroscience, neuromodulatory mechanisms, and software
- **Regulatory First-Mover Status**: First FDA-cleared prescription app for MDD (Rejoyn) and multiple FDA authorizations (AspyreRx for diabetes, CT-132 for migraine)
- **Deep Pharma Partnerships**: Collaborations with Otsuka, Boehringer Ingelheim, Sanofi – providing validation, co-development, and commercialization infrastructure
- **Intellectual Property**: Coined the term "Digital Therapeutics™"; broad pipeline across psychiatry, neurology, cardiology, oncology, immunology

## Strategic Focus
- **Commercialization**: Scaling Rejoyn and AspyreRx post-FDA authorization; expanding payer coverage and physician adoption
- **Pipeline Expansion**: Advancing CT-132 (migraine) and CT-155 (schizophrenia) through pivotal trials towards FDA submissions
- **Platform Development**: Enhancing Click SE platform for Software-Enhanced Drugs™, enabling faster creation of combo treatments with pharma partners
- **Market Expansion**: Building global partnerships (e.g., Ultrahuman for biomarker-driven migraine tools) and exploring new therapeutic areas

## Why Work Here
- **Work Environment**: Hybrid/office-first locations in New York (Tribeca) and Boston; collaborative, open-plan office with rooftop perks, happy hours, and team outings
- **Culture**: Described as "exciting and inclusive" with a strong mission-driven focus; pre-IPO growth stage offers wealth-building opportunity
- **Benefits** (from [careers page](https://www.clicktherapeutics.com/careers)):
  - Unlimited PTO
  - 401k with 100% match up to 5%
  - Professional development stipend (yearly)
  - Caregiving stipend (childcare, eldercare, pet care)
  - Comprehensive medical, dental, vision (with mental health resources)
  - One Medical membership (primary care + EAP)
  - Fertility care and family-building support
- **Engineering Culture**: Multidisciplinary teams (clinicians, researchers, technologists, designers) building regulated software-as-medical-device; emphasis on innovation and patient impact
- **Awards**: BuiltIn Best Places to Work (NYC) 2025 – recognized for compensation, total rewards, and culture programs

## Sources
1. [Click Therapeutics About Page](https://www.clicktherapeutics.com/about)
2. [Click Therapeutics Homepage](https://www.clicktherapeutics.com/)
3. [Click Therapeutics Careers](https://www.clicktherapeutics.com/careers)
4. [Click Therapeutics Team](https://www.clicktherapeutics.com/team)
5. [CB Insights Company Profile](https://www.cbinsights.com/company/click-therapeutics)
6. [Click Therapeutics & Boehringer Ingelheim Series D Announcement](https://www.clicktherapeutics.com/news/click-therapeutics-and-boehringer-ingelheim-announce-series-d-investment-and-funding-to-advance-commercialization-of-ct-155)
7. [Ultrahuman Partnership Announcement](https://www.clicktherapeutics.com/news/ultrahuman-and-click-therapeutics-partner-to-launch-the-worlds-first-biomarker-driven-migraine-management-tool-based-on-fda-authorized-technology)
8. [ReMMi-D Trial Results](https://www.clicktherapeutics.com/news/click-therapeutics-ct-132-investigational-prescription-digital-therapeutic-for-preventive-treatment-of-episodic-migraine-meets-primary-endpoint-in-remmi-d-pivotal-trial)
9. [CONVOKE Study Results](https://www.clicktherapeutics.com/news/boehringer-and-click-therapeutics-investigational-prescription-digital-therapeutic-ct-155-meets-primary-endpoint-in-convoke-study-for-negative-symptoms-in-schizophrenia)

## Other roles at Click Therapeutics

- [Director, Marketing (Rx and OTC)](https://feeny.ai/job/director-marketing-rx-and-otc-click-therapeutics-new-york-8932ta9ddqcx) — New York, NY
- [Senior/Staff Software Engineer](https://feeny.ai/job/senior-staff-software-engineer-click-therapeutics-new-york-ny-or-boston-338kj415xwgt) — New York NY OR Boston, MA
- [Director/Senior Director, Science](https://feeny.ai/job/director-senior-director-science-click-therapeutics-new-york-ny-or-boston-ma-mwba9hg3e5j4) — New York NY OR Boston MA, OR
- [Senior Director/Vice President, Marketing (Rx and OTC)](https://feeny.ai/job/senior-director-vice-president-marketing-rx-and-otc-click-therapeutics-new-york-dakg5emx136v) — New York, NY
- [Information Security Lead](https://feeny.ai/job/information-security-lead-click-therapeutics-new-york-ny-or-boston-3scb9wmh7mzr) — New York NY OR Boston, MA
- [Join Our Talent Community](https://feeny.ai/job/join-our-talent-community-gillig-livermore-c9p1pgd99x5d) — Livermore, CA
- [Join Our Talent Community](https://feeny.ai/job/join-our-talent-community-bridgebio-pharma-san-francisco-rn1egn51cznq) — San Francisco, CA
- [Join Our Talent Community](https://feeny.ai/job/join-our-talent-community-ensafe-inc-united-states-57pp4htweaph) — United States
- [Join Our Talent Community](https://feeny.ai/job/join-our-talent-community-atwell-llc-atwell-jd1ky7wnj640) — Atwell
- [Join Our Talent Community](https://feeny.ai/job/join-our-talent-community-blue-j-toronto-r7xm7cacg3hz) — Toronto, Canada